大庆糖尿病预防研究II:数字与综合生活方式干预预防2型糖尿病的三臂整群随机对照试验方案
BACKGROUND: The Daqing Diabetes Prevention Study II (Daqing DPS-II) builds on the landmark study Daqing Diabetes Prevention Study to develop real-world implementation strategies for preventing type 2 diabetes (T2DM).…
要点
- 在真实世界工厂环境中比较数字与综合生活方式干预预防2型糖尿病的效果。
- 主要结局为3年2型糖尿病累积发病率,干预持续3年。
- 采用RE-AIM框架和实施结局框架评估过程指标。
核心结论
- 该研究将提供数字和综合生活方式干预在真实世界环境中预防糖尿病的实施证据。
- 若被证明有效,这些策略可整合入工作场所健康计划以预防糖尿病和其他非传染性疾病。
研究设计与样本
- 三臂、分层、整群随机对照试验,在大庆8家工厂开展,以整群为随机化单位、个体为分析单位。
- 纳入25-55岁2型糖尿病风险增高成人, defined by IFG、IGT、HbA1c 5.7-6.4%和/或1-h PG above 8.6 mmol/L,且不符合糖尿病标准。
- 排除标准包括6个月内显著心血管疾病、肝功能损害、肾功能不全、其他显著医学或心理状况、参与类似研究。
- 干预运行3年,主要结局为3年2型糖尿病累积发病率。
关键数值与推荐
- 2型糖尿病风险增高定义:IFG、IGT、HbA1c 5.7-6.4%和/或1-h PG above 8.6 mmol/L,且不符合糖尿病标准。
- 主要结局为3年2型糖尿病累积发病率。
- 采用RE-AIM框架和实施结局框架(IOF)评估 reach、adoption、implementation、maintenance、feasibility、acceptability 和 appropriateness。
- 数据收集包括口服葡萄糖耐量试验的血糖(0、1、2小时)和胰岛素水平(0、1、2小时)、实验室检查、血压、体重指数、腰围、饮食和身体活动行为、糖尿病知识和生活质量。
- 在基线及6、12、24、36个月随访时由培训过的医生或护士评估。
临床怎么用
- 为工作场所健康计划整合数字或综合生活方式干预预防2型糖尿病提供实施依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Daqing Diabetes Prevention Study II (Daqing DPS-II) builds on the landmark study Daqing Diabetes Prevention Study to develop real-world implementation strategies for preventing type 2 diabetes (T2DM). This study aims to evaluate the effectiveness of digital and complex lifestyle intervention in reducing the incidence of T2DM among adults with increased risk of T2DM, compared to usual care over a 36-month period. METHODS: A three-arm, stratified, cluster-randomized controlled trial will be conducted in eight factories in Daqing, with clusters as the unit of randomization and individual participants as the unit of analysis. Fifty-seven clusters will be randomly allocated (1:1:1) to one of three groups: (1) Digital-based lifestyle intervention, (2) complex lifestyle intervention, or (3) usual care. Eligible participants will be adults aged 25-55 with increased risk of T2DM, defined by IFG, IGT, HbA1c 5.7-6.4%, and/or 1-h PG above 8.6 mmol/L, while not meeting the criteria for diabetes. Exclusion criteria include significant cardiovascular disease (CVD) within 6 months, impaired liver function, renal dysfunction, other significant medical or psychological conditions, or participation in similar studies. The interventions will run for 3 years. The primary outcomes are the 3-year cumulative incidence of T2DM. The study will utilize the RE-AIM framework and Implementation Outcome Framework (IOF) to assess Reach, Adoption, Implementation, Maintenance, Feasibility, Acceptability, and Appropriateness through process measures. Data collection will include plasma glucose (0, 1, and 2 h) and insulin levels (0, 1, and 2 h) based on the oral glucose tolerance test, laboratory tests, blood pressure, body mass index, waist circumference, and dietary and physical activity behaviors, diabetes knowledge, and quality of life. These measures will be assessed by trained doctors or nurses at baseline and at 6-,12-, 24-, and 36-month follow-ups. DISCUSSION: The study will provide evidence on how population-level strategies of digital and complex lifestyle intervention can be implemented in real-world settings to prevent diabetes. If proven effective, these strategies could be integrated into Workplace Wellness Program in China and other countries to prevent diabetes and other noncommunicable diseases. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400080790. Registered on 7th February 2024 TRIAL ACRONYM: Daqing DPS-II: Daqing Diabetes Prevention Study II.
引用
- Zhang J, Li D, Wang Y, et al. A three-arm, parallel group, cluster randomized controlled trial to evaluate digital and complex lifestyle interventions as compared with usual care for type 2 diabetes prevention: protocol for the Daqing Diabetes Prevention Study II (Daqing DPS-II). Trials. 2026. PMID: 41634765. doi:10.1186/s13063-025-09400-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。